Matches in Wikidata for { <http://www.wikidata.org/entity/Q83962653> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q83962653 description "2006 թվականի հունիսի 12-ին հրատարակված գիտական հոդված" @default.
- Q83962653 description "article scientifique publié en 2006" @default.
- Q83962653 description "artículu científicu espublizáu en xunu de 2006" @default.
- Q83962653 description "im Juni 2006 veröffentlichter wissenschaftlicher Artikel" @default.
- Q83962653 description "scientific article published on 12 June 2006" @default.
- Q83962653 description "wetenschappelijk artikel" @default.
- Q83962653 description "наукова стаття, опублікована в червні 2006" @default.
- Q83962653 name "During 3 years treatment of primary progressive multiple sclerosis with glatiramer acetate, specific antibodies switch from IgG1 to IgG4" @default.
- Q83962653 name "During 3 years treatment of primary progressive multiple sclerosis with glatiramer acetate, specific antibodies switch from IgG1 to IgG4" @default.
- Q83962653 type Item @default.
- Q83962653 label "During 3 years treatment of primary progressive multiple sclerosis with glatiramer acetate, specific antibodies switch from IgG1 to IgG4" @default.
- Q83962653 label "During 3 years treatment of primary progressive multiple sclerosis with glatiramer acetate, specific antibodies switch from IgG1 to IgG4" @default.
- Q83962653 prefLabel "During 3 years treatment of primary progressive multiple sclerosis with glatiramer acetate, specific antibodies switch from IgG1 to IgG4" @default.
- Q83962653 prefLabel "During 3 years treatment of primary progressive multiple sclerosis with glatiramer acetate, specific antibodies switch from IgG1 to IgG4" @default.
- Q83962653 P1433 Q83962653-F89F84BC-6CFC-4138-9F96-AFD2394B7176 @default.
- Q83962653 P1476 Q83962653-827C37F0-F4F2-45E5-BDAA-51D128AB29D5 @default.
- Q83962653 P2093 Q83962653-0FB808EB-E71D-4104-B1A5-F896768FBB3F @default.
- Q83962653 P2093 Q83962653-8A2F7863-90CD-41AF-8B85-D322C4529C56 @default.
- Q83962653 P2093 Q83962653-F630C080-B982-474A-831F-4F8668F9F908 @default.
- Q83962653 P2093 Q83962653-FD84CDD2-CE5D-401B-A390-61F227945DC5 @default.
- Q83962653 P304 Q83962653-32416AEE-87FA-4486-AC67-D5AE3393E043 @default.
- Q83962653 P31 Q83962653-7652EE99-045B-44F6-87A7-8B5C9DDE8585 @default.
- Q83962653 P356 Q83962653-C776D8EC-DB0E-489A-ABD7-0498F945675F @default.
- Q83962653 P433 Q83962653-AEF6F455-3474-4E24-A4C0-D17C81C89F49 @default.
- Q83962653 P478 Q83962653-206268D2-D5C1-4E77-A8C0-845D3C532E76 @default.
- Q83962653 P577 Q83962653-C3CF9A36-C79C-4B26-B8B4-B6C3C31BB4F9 @default.
- Q83962653 P698 Q83962653-BED17F39-17DF-4126-B932-3AE808814FFC @default.
- Q83962653 P921 Q83962653-1FA0A37F-01F1-4618-92BD-2935A2BFC8DE @default.
- Q83962653 P921 Q83962653-B252AA04-FE8F-464B-AD73-639DF7EA280C @default.
- Q83962653 P356 J.JNEUROIM.2006.04.024 @default.
- Q83962653 P698 16765453 @default.
- Q83962653 P1433 Q15716691 @default.
- Q83962653 P1476 "During 3 years treatment of primary progressive multiple sclerosis with glatiramer acetate, specific antibodies switch from IgG1 to IgG4" @default.
- Q83962653 P2093 "Ebrima Gibbs" @default.
- Q83962653 P2093 "Erika Basile" @default.
- Q83962653 P2093 "Joel Oger" @default.
- Q83962653 P2093 "Tariq Aziz" @default.
- Q83962653 P304 "161-166" @default.
- Q83962653 P31 Q13442814 @default.
- Q83962653 P356 "10.1016/J.JNEUROIM.2006.04.024" @default.
- Q83962653 P433 "1-2" @default.
- Q83962653 P478 "177" @default.
- Q83962653 P577 "2006-06-12T00:00:00Z" @default.
- Q83962653 P698 "16765453" @default.
- Q83962653 P921 Q18553470 @default.
- Q83962653 P921 Q8277 @default.